These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 8854644

  • 1. Effects of nitric oxide (NO) synthesis inhibition on antitumor responses during interleukin-2 (IL-2) treatment of mice.
    Yim CY, Lee CW, Choi SM, Park SS, Lee SJ, Kim JH, Song JS, Yoo WH, Kwak JY, Sohn MH.
    Korean J Intern Med; 1996 Jun; 11(2):93-100. PubMed ID: 8854644
    [Abstract] [Full Text] [Related]

  • 2. Nitric oxide synthesis contributes to IL-2-induced antitumor responses against intraperitoneal Meth A tumor.
    Yim CY, McGregor JR, Kwon OD, Bastian NR, Rees M, Mori M, Hibbs JB, Samlowski WE.
    J Immunol; 1995 Nov 01; 155(9):4382-90. PubMed ID: 7594598
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness and toxicity of protracted nitric oxide synthesis inhibition during IL-2 treatment of mice.
    Samlowski WE, Yim CY, McGregor JR, Kwon OD, Gonzales S, Hibbs JB.
    J Immunother Emphasis Tumor Immunol; 1995 Oct 01; 18(3):166-78. PubMed ID: 8770772
    [Abstract] [Full Text] [Related]

  • 4. Nitric oxide synthesis contributes to inhibition of graft-versus-tumor-effects against intraperitoneal Meth A tumor.
    Song EK, Lee NR, Sohn MH, Kwak JY, Yim CY.
    Cell Immunol; 2004 Aug 01; 230(2):109-18. PubMed ID: 15598426
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of N(G)-Nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, on IL-2-induced LAK cell generation in vivo and in vitro in healthy and tumor-bearing mice.
    Orucevic A, Lala PK.
    Cell Immunol; 1996 Apr 10; 169(1):125-32. PubMed ID: 8612285
    [Abstract] [Full Text] [Related]

  • 7. Effects of N(g)-methyl-L-arginine, an inhibitor of nitric oxide synthesis, on interleukin-2-induced capillary leakage and antitumor responses in healthy and tumor-bearing mice.
    Orucevic A, Lala PK.
    Cancer Immunol Immunother; 1996 Jan 10; 42(1):38-46. PubMed ID: 8625365
    [Abstract] [Full Text] [Related]

  • 8. Modulation of IL-1-induced cartilage injury by NO synthase inhibitors: a comparative study with rat chondrocytes and cartilage entities.
    Cipolletta C, Jouzeau JY, Gegout-Pottie P, Presle N, Bordji K, Netter P, Terlain B.
    Br J Pharmacol; 1998 Aug 10; 124(8):1719-27. PubMed ID: 9756389
    [Abstract] [Full Text] [Related]

  • 9. Interleukin 1 alpha and gamma-interferon induction of nitric oxide production from murine tumor-derived endothelial cells.
    Chang MJ, Modzelewski RA, Russell DM, Johnson CS.
    Cancer Res; 1996 Feb 15; 56(4):886-91. PubMed ID: 8631029
    [Abstract] [Full Text] [Related]

  • 10. Interleukin 12 primes macrophages for nitric oxide production in vivo and restores depressed nitric oxide production by macrophages from tumor-bearing mice: implications for the antitumor activity of interleukin 12 and/or interleukin 2.
    Wigginton JM, Kuhns DB, Back TC, Brunda MJ, Wiltrout RH, Cox GW.
    Cancer Res; 1996 Mar 01; 56(5):1131-6. PubMed ID: 8640772
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of interleukin-1-alpha-induced nitric oxide synthase in vascular smooth muscle and full reversal of interleukin-1-alpha-induced hypotension by N omega-amino-L-arginine.
    Kilbourn RG, Gross SS, Lodato RF, Adams J, Levi R, Miller LL, Lachman LB, Griffith OW.
    J Natl Cancer Inst; 1992 Jul 01; 84(13):1008-16. PubMed ID: 1376778
    [Abstract] [Full Text] [Related]

  • 12. N omega -monomethyl-L-arginine inhibits nitric oxide production in murine cardiac allografts but does not affect graft rejection.
    Bastian NR, Xu S, Shao XL, Shelby J, Granger DL, Hibbs JB.
    Biochim Biophys Acta; 1994 May 25; 1226(2):225-31. PubMed ID: 7515690
    [Abstract] [Full Text] [Related]

  • 13. Use of curcumin to decrease nitric oxide production during the induction of antitumor responses by IL-2.
    Song MY, Yim JY, Yim JM, Kang IJ, Rho HW, Kim HS, Yhim HY, Lee NR, Song EK, Kwak JY, Sohn MH, Yim CY.
    J Immunother; 2011 Mar 25; 34(2):149-64. PubMed ID: 21304405
    [Abstract] [Full Text] [Related]

  • 14. Activated peritoneal macrophages inhibit the proliferation of rat ascites hepatoma AH-130 cells via the production of tumor necrosis factor-alpha and nitric oxide.
    Maekawa H, Iwabuchi K, Nagaoka I, Watanabe H, Kamano T, Tsurumaru M.
    Inflamm Res; 2000 Oct 25; 49(10):541-7. PubMed ID: 11089907
    [Abstract] [Full Text] [Related]

  • 15. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
    Sternesjö J, Welsh N, Sandler S.
    Cytokine; 1997 May 25; 9(5):352-9. PubMed ID: 9195135
    [Abstract] [Full Text] [Related]

  • 16. Interleukin-1 beta-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase.
    Welsh N, Eizirik DL, Bendtzen K, Sandler S.
    Endocrinology; 1991 Dec 25; 129(6):3167-73. PubMed ID: 1720090
    [Abstract] [Full Text] [Related]

  • 17. Alveolar macrophages autoregulate IL-1 and IL-6 production by endogenous nitric oxide.
    Persoons JH, Schornagel K, Tilders FF, De Vente J, Berkenbosch F, Kraal G.
    Am J Respir Cell Mol Biol; 1996 Mar 25; 14(3):272-8. PubMed ID: 8845178
    [Abstract] [Full Text] [Related]

  • 18. Suppressive effects of a selective inducible nitric oxide synthase (iNOS) inhibitor on pancreatic beta-cell dysfunction.
    Kato Y, Miura Y, Yamamoto N, Ozaki N, Oiso Y.
    Diabetologia; 2003 Sep 25; 46(9):1228-33. PubMed ID: 12898012
    [Abstract] [Full Text] [Related]

  • 19. Effect of in vivo inhibition of nitric oxide production in murine leishmaniasis.
    Evans TG, Thai L, Granger DL, Hibbs JB.
    J Immunol; 1993 Jul 15; 151(2):907-15. PubMed ID: 8335918
    [Abstract] [Full Text] [Related]

  • 20. The intravenous administration of tumor necrosis factor alpha, interleukin 8 and macrophage-derived neutrophil chemotactic factor inhibits neutrophil migration by stimulating nitric oxide production.
    Tavares-Murta BM, Cunha FQ, Ferreira SH.
    Br J Pharmacol; 1998 Aug 15; 124(7):1369-74. PubMed ID: 9723947
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.